Exagen

AVISE provides advanced Diagnosis, Prognosis & Monitoring lupus and autoimmune disease testing. Vis www.AviseTest.com

AVISE provides advanced clinical tools for the
Diagnosis, Prognosis & Monitoring of
Autoimmune Connective Tissue Diseases such as, Rheumatoid Arthritis, Lupus, Sjögren’s & Mixed Connective Tissue Disease among others.

10/16/2025

We look forward to hearing Andrea Fava, MD, present his groundbreaking research, "Urinary Tenascin C Predicts Kidney Function Loss in Lupus Nephritis" at ACR Convergence 2025.

This 15-minute Plenary Talk will highlight novel biomarkers with the potential to enhance early detection and improve management of lupus nephritis.

📍Session Details:
• Location: McCormick Place, Lower Level, Exhibit Hall F2
• Date & Time: October 27th, 2025, 6:30-6:45 AM

🎤 Presentation Title:
• Urinary Tenascin C Predicts Kidney Function Loss in Lupus Nephritis

10/15/2025

We're honored to host an Innovation Theater Presentation at ACR Convergence 2025. Join us as we explore the science shaping the future of autoimmune diagnostics.

📍 Event Details
• Location: McCormick Place Convention Center | Chicago, IL
• Date & Time: Monday, October 27 | 2:30-3:15 PM CDT
• Theater: Innovation Theater A

🎤 Presentation Title:
AVISE® CTD: A Decade of Validation Driving Lupus Diagnostic Accuracy, Seronegative RA Biomarker Innovation, and Novel T Cell Biomarkers for Lupus.

🗣️ Featured Speakers:
• Alvin Wells, MD, PhD, FACP, FACR
• Vasileios Kyttaris, MD, PhD, FACR

We look forward to sharing new insights that continue to advance lupus and rheumatoid arthritis diagnosis and patient care.

10/14/2025

Exagen is proud to announce that we will be attending and presenting at ACR Convergence 2025 in Chicago from October 24-29.

📍 Stop by booth #1228 to learn how we're leading the science of autoimmune disease diagnostics.
At Exagen, our mission is simple: to improve the lives of patients suffering from autoimmune diseases by delivering innovative, trusted diagnostic solutions that empower physicians with clarity and confidence.

We look forward to connecting with the rheumatology community, sharing our latest advancements, and discussing how together we can help drive earlier, more accurate diagnoses and better patient outcomes.

09/19/2025

“I've been evaluating anti-PAD antibodies in research settings, and I think they have a role in improving diagnosis and prognosis in RA, as well as a role in helping us to understand the biology of RA development. I'm happy to see anti-PAD antibodies becoming available for clinical testing in the USA to help improve the diagnosis of RA."

Kevin Deane, MD
Professor and Rheumatologist at the University of Colorado Denver School of Medicine

Learn more about Exagen’s newest biomarkers, anti-PAD4 IgA and IgG: https://avisetest.com/provider/avise-ra/

09/12/2025

Peptidylarginine deiminases (PADs) play a crucial role in the production of citrullinated proteins, the hallmark autoantigens of Rheumatoid Arthritis (RA). Anti-PAD4 autoantibodies target a key enzyme involved in the citrullination process.

Unlike traditional biomarkers, anti-PAD4 can be present in patients who are seronegative for RF and anti-CCP, helping clinicians identify RA earlier in the disease course. By providing additional diagnostic and prognostic insight, anti-PAD4 supports earlier intervention and greater confidence when differentiating RA from other inflammatory arthritides, especially in clinically ambiguous cases.

Learn more about Exagen’s newest biomarkers: https://avisetest.com/provider/avise-ra/

09/08/2025

Peptidylarginine deiminases (PADs) play a crucial role in the production of citrullinated proteins, the hallmark autoantigens of Rheumatoid Arthritis (RA). Anti-PAD4 autoantibodies target a key enzyme involved in the citrullination process.
We're excited to announce the addition of two new innovative seronegative rheumatoid arthritis (RA) biomarkers, anti-PAD4 IgG and IgA, now included with every AVISE® CTD test.

With up to 30% of RA patients testing negative for conventional biomarkers anti-CCP and rheumatoid factor, anti-PAD4 biomarkers provide greater diagnostic sensitivity. This allows clinicians to identify seronegative RA earlier, enhance diagnostic clarity, and gain valuable prognostic insights to help guide clinical decision-making.

Available starting today.

Learn more: https://avisetest.com/provider/avise-ra/

08/19/2025

Don’t forget to register for our upcoming webinar on innovative and comprehensive serological testing in autoimmune disease diagnostics. Learn how AVISE® CTD is helping improve diagnostic accuracy and patient outcomes—secure your spot today.

https://xtalks.com/webinars/beyond-diagnosis-the-real-world-impact-of-avise-testing-on-lupus-rheumatoid-arthritis-and-autoimmune-disease-care/

08/14/2025

Join our webinar to learn how innovative serological testing is transforming diagnostic accuracy for , , and other connective tissue diseases. Gain practical insights through real-world case studies, and learn how enhanced diagnostics via AVISE® CTD are improving patient outcomes and streamlining clinical practice —register now!

https://xtalks.com/webinars/beyond-diagnosis-the-real-world-impact-of-avise-testing-on-lupus-rheumatoid-arthritis-and-autoimmune-disease-care/

05/30/2025

A huge thank you to everyone who participated in our "Give for Lupus" blood drive with the American Red Cross and helped spread awareness all month long. Your support means everything—and we’re proud to stand together in the fight against lupus. Let’s keep the momentum going—because raising awareness and supporting those impacted by lupus is a year-round commitment.

05/15/2025

T Cell biomarkers are emerging as powerful tools in the early detection of . Learn more: https://ow.ly/k2GT50VS0bG

05/10/2025

Exagen put on purple for to shine a light on this invisible illness through science, awareness, and support.

05/01/2025

May is Lupus Awareness Month. Join us in raising awareness for the millions affected by this complex . Ongoing research and development leads to earlier diagnosis, better care, and hope for a cure. www.avisetest.com

Address

1261 Liberty Way
Vista, CA
92081

Telephone

+18884521522

Website

http://www.exagen.com/patient-info/test-for-lupus/

Alerts

Be the first to know and let us send you an email when Exagen posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Exagen:

Shortcuts

Want your practice to be the top-listed Clinic in Vista?